Security
Kraig Biocraft Laboratories, Inc. Common Stock · KBLB
KBLBOTCCommon stockCurrentCIK 1413119Updated Nov 17, 2026
KBLB price & chart
Loading TradingView…
OTC:KBLB on TradingView ↗In the news
These Stocks Roar into October with Fresh Catalysts ↗
Recent filings
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 2,356,596Source | 2,026,358Source | 4,271,792Source | 1,591,332Source | 2,219,834Source | 3,721,832Source | 1,316,047Source | 2,772,489Source | 2,565,540Source | 1,505,333Source | 3,232,822Source | 4,570,920Source |
| Property, Plant and Equipment, NetUSD | 30,993Source | 46,533Source | 54,403Source | 36,984Source | 53,181Source | 32,897Source | 39,038Source | 59,911Source | 25,003Source | 44,721Source | 66,640Source | 87,861Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 1,565,692Source | 1,190,027Source | 3,391,646Source | 785,462Source | 1,521,531Source | 2,890,990Source | 397,001Source | 2,047,307Source | 1,790,236Source | 673,264Source | 2,551,834Source | — |
| Inventory, NetUSD | 29,067Source | 6,884Source | 134,142Source | 6,884Source | 6,884Source | 74,307Source | 6,884Source | 6,884Source | 29,067Source | 6,884Source | 6,884Source | 6,580Source |
| Assets, CurrentUSD | 1,639,921Source | 1,238,140Source | 3,574,845Source | 838,975Source | 1,533,863Source | 3,010,459Source | 452,714Source | 2,058,234Source | 1,868,641Source | 740,285Source | 2,573,620Source | 3,983,441Source |
| Operating Lease, Right-of-Use AssetUSD | 184,030Source | 39,489Source | 6,212Source | 58,426Source | 71,847Source | 156,635Source | 72,568Source | 114,027Source | 170,463Source | 86,088Source | 95,808Source | 58,849Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 10,312,673Source | 9,383,367Source | 11,022,908Source | 10,064,196Source | 9,191,513Source | 10,783,506Source | 9,863,845Source | 9,014,518Source | 10,564,498Source | 9,654,954Source | 8,939,978Source | 8,092,780Source |
| Stockholders’ equity: | ||||||||||||
| Additional Paid in CapitalUSD | 12,342,344Source | 12,231,624Source | 12,619,910Source | 12,232,665Source | 12,183,754Source | 12,670,302Source | 12,144,729Source | 11,307,215Source | 12,434,886Source | 12,290,687Source | 11,354,213Source | 10,834,729Source |
| Retained Earnings (Accumulated Deficit)USD | -55,921,451Source | -52,234,044Source | -58,561,327Source | -54,411,885Source | -51,800,844Source | -57,651,792Source | -53,685,752Source | -50,194,655Source | -56,709,072Source | -53,085,719Source | -49,686,780Source | -46,657,000Source |
| Stockholders' Equity Attributable to ParentUSD | -7,956,077Source | -7,357,009Source | -6,751,116Source | -8,472,864Source | -6,971,679Source | -7,061,674Source | -8,547,798Source | -6,242,029Source | -7,998,958Source | -8,149,621Source | -5,707,156Source | -3,521,860Source |
| Liabilities and EquityUSD | 2,356,596Source | 2,026,358Source | 4,271,792Source | 1,591,332Source | 2,219,834Source | 3,721,832Source | 1,316,047Source | 2,772,489Source | 2,565,540Source | 1,505,333Source | 3,232,822Source | 4,570,920Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 10,184,705Source | 9,340,819Source | 10,901,744Source | 10,029,698Source | 9,146,075Source | 10,677,075Source | 9,826,119Source | 8,956,527Source | 10,445,245Source | 9,614,428Source | 8,885,610Source | 8,072,083Source |
| Operating Lease, Liability, CurrentUSD | 56,062Source | 57,518Source | 72,843Source | 24,278Source | 57,542Source | 51,604Source | 35,542Source | 56,736Source | 51,909Source | 46,948Source | 41,789Source | 39,200Source |
| Operating Lease, Liability, NoncurrentUSD | 127,968Source | 42,548Source | 121,164Source | 34,498Source | 45,438Source | 106,431Source | 37,726Source | 57,991Source | 119,253Source | 40,526Source | 54,368Source | 20,697Source |
| Additional Financial Items | ||||||||||||
| Accrued Liabilities, CurrentUSD | — | — | — | — | — | — | — | — | — | — | — | 107,882Source |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | 45,240Source | — | 22,183Source | — | 304Source | 6,580Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -529,718Source | -434,499Source | -1,788,970Source | -1,839,086Source | -1,244,483Source | -1,887,187Source |
| Cash flows from investing activities: | ||||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | -14,116Source | — | 438,042Source | -4,240Source | -6,399Source | -5,021Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | 14,116Source | — | 5,395Source | 4,240Source | 6,399Source | 5,021Source |
| Cash flows from financing activities: | ||||||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 1,644,588Source | 158,236Source | 2,467,900Source | -35,244Source | -60,000Source | 3,399,864Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | 1,100,754Source | -276,263Source | 1,116,972Source | -1,878,570Source | -1,310,882Source | 1,507,656Source |
| Additional Financial Items | ||||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | — | — | — | — | 29,085Source | — | 87,285Source | — | — | — |
| Amortization of Debt Issuance CostsUSD | — | — | — | — | — | — | — | — | — | — | — | 1,111,580Source |
| DepreciationUSD | — | — | 5,992Source | 6,649Source | 7,102Source | 5,837Source | 6,222Source | 5,683Source | 25,113Source | 26,159Source | 27,620Source | 28,103Source |
| Gain (Loss) on Sale of Assets and Asset Impairment ChargesUSD | — | — | — | 30,084Source | — | — | — | — | 200,433Source | — | — | 0Source |
| General and Administrative ExpenseUSD | — | — | 1,199,955Source | 205,298Source | 374,381Source | 344,035Source | 495,566Source | 308,851Source | 1,958,768Source | 1,747,585Source | 1,454,295Source | 825,460Source |
| InterestExpenseNonoperatingUSD | — | — | 144,255Source | 132,890Source | 151,399Source | 141,986Source | 148,433Source | 140,348Source | 570,709Source | 529,603Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | — | — | -1,509,566Source | -433,200Source | -909,535Source | -726,133Source | -942,720Source | -600,033Source | -3,623,353Source | -3,398,939Source | -3,029,780Source | -3,842,014Source |
| Nonoperating Income (Expense)USD | — | — | -75,678Source | -9,403Source | — | -88,388Source | — | -19,541Source | — | -324,378Source | -414,986Source | -1,720,671Source |
| Operating ExpensesUSD | — | — | 1,433,888Source | 423,797Source | 703,433Source | 637,745Source | 825,500Source | 580,492Source | 3,374,793Source | 3,074,561Source | 2,614,794Source | 2,121,343Source |
| Other Nonoperating Income (Expense)USD | — | — | — | — | -206,102Source | -88,388Source | -117,220Source | -19,541Source | -248,560Source | — | — | — |
| Realized Investment Gains (Losses)USD | — | — | 124,328Source | — | — | — | — | — | 233,028Source | — | — | — |
| Unrealized Gain (Loss) on Investments | — | — | —Source | —Source | —Source | —Source | —Source | —Source | — | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Income (Loss)USD | — | — | -1,433,888Source | -423,797Source | -703,433Source | -637,745Source | -825,500Source | -580,492Source | -3,374,793Source | -3,074,561Source | -2,614,794Source | -2,121,343Source |
| Other Nonoperating Income (Expense)USD | — | — | — | — | -206,102Source | -88,388Source | -117,220Source | -19,541Source | -248,560Source | — | — | — |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | -1,509,566Source | -433,200Source | -909,535Source | -726,133Source | -942,720Source | -600,033Source | -3,623,353Source | -3,398,939Source | -3,029,780Source | -3,842,014Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -1,509,566Source | -433,200Source | -909,535Source | -726,133Source | -942,720Source | -600,033Source | -3,623,353Source | -3,398,939Source | -3,029,780Source | -3,842,014Source |
| Earnings Per Share, BasicUSD per share | — | — | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source |
| Earnings Per Share, DilutedUSD per share | — | — | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | — |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 1,068,264,462Source | 1,038,374,219Source | 1,110,343,050Source | 1,047,493,242Source | 1,090,869,198Source | 1,041,458,063Source | 1,059,485,670Source | 1,038,374,219Source | 1,033,122,597Source | 974,307,366Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 1,068,264,462Source | 1,038,374,219Source | 1,110,343,050Source | 1,047,493,242Source | 1,090,869,198Source | 1,041,458,063Source | 1,059,485,670Source | 1,038,374,219Source | 1,033,122,597Source | — |
| Interest Expense (non-operating)USD | — | — | 144,255Source | 132,890Source | 151,399Source | 141,986Source | 148,433Source | 140,348Source | 570,709Source | 529,603Source | — | — |
| Additional Financial Items | ||||||||||||
| General and Administrative ExpenseUSD | — | — | 1,199,955Source | 205,298Source | 374,381Source | 344,035Source | 495,566Source | 308,851Source | 1,958,768Source | 1,747,585Source | 1,454,295Source | 825,460Source |
| Interest and Other IncomeUSD | — | — | 1,118Source | 14,983Source | 19,312Source | 1,140Source | 10,805Source | 3,319Source | 11,518Source | 71,396Source | — | — |
| Interest Expense, DebtUSD | — | — | — | — | — | — | — | — | — | — | — | 153,955Source |
| Interest Income, OperatingUSD | — | — | — | — | — | — | — | — | — | — | 109,559Source | — |
| Nonoperating Income (Expense)USD | — | — | -75,678Source | -9,403Source | — | -88,388Source | — | -19,541Source | — | -324,378Source | -414,986Source | -1,720,671Source |
| Operating ExpensesUSD | — | — | 1,433,888Source | 423,797Source | 703,433Source | 637,745Source | 825,500Source | 580,492Source | 3,374,793Source | 3,074,561Source | 2,614,794Source | 2,121,343Source |
| Other IncomeUSD | — | — | 98,427Source | — | — | — | — | — | 200,433Source | — | — | — |
| Realized Investment Gains (Losses)USD | — | — | 124,328Source | — | — | — | — | — | 233,028Source | — | — | — |
| Research and Development ExpenseUSD | — | — | 9,243Source | 24,968Source | 64,369Source | 63,888Source | 66,701Source | 23,876Source | 165,758Source | 164,374Source | 237,871Source | 176,431Source |
Offerings
Registration 333-262631
Registration 333-284773
Filing attachments
ex107.htm · S-1 · 2025-02-07
EX-FILING FEES 3 ex107.htm CALCULATION OF FILING FEE TABLES Exhibit 107 Calculation of Filing Fee Tables FORM S-1 (Form Type) Kraig Biocraft Laboratories, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered (1) Proposed Maximum Offering Price Maximum Aggregate Offering Price Fee Rate A…
Read attachment ↗ex99-1.htm · 8-K · 2025-01-21
EX-99.1 3 ex99-1.htm Exhibit 99.1 Kraig Biocraft Laboratories Secures $10 Million SEPA to Support Spider Silk Production Growth and Commercialization ANN ARBOR, Mich., - January 21, 2025 - Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company” or “Kraig Labs”), a leading developer of spider silk-based fibers, announces that it has secured $10 million in a standby equity purchase agreement (“SEPA”) with YA II PN, Ltd. (“Yorkville”). This agreement will provide the Company with access…
Read attachment ↗